Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.

BACKGROUND Although ultrasound (US) features of papillary thyroid carcinoma (PTC) are well established, little is known regarding biological behavior according US features. We investigated whether there was a difference in biological behavior between PTCs that did and did not meet malignant US criteria. PATIENTS AND METHODS We retrospectively reviewed clinical records and histological and US findings of the index tumors in 488 patients who underwent surgery for PTC. Benign-looking PTC (B-PTC) was defined as showing none of the accepted US criteria for malignancy. Malignant-looking PTCs (M-PTCs) and B-PTCs were compared in terms of patients' age, sex, tumor size, histological subtype, multifocality, lymph node (LN) metastasis, extrathyroidal extension, stage, recurrence, and distant metastasis. RESULTS B-PTCs accounted for 74 (15%) of all 488 PTCs. Mean tumor size was not significantly different between the groups, with 1.10 cm for M-PTC and 1.11 cm for B-PTC (P = .947). Univariate and multivariate analysis indicated that M-PTC more frequently had LN metastasis, extrathyroidal extension, and a higher stage than B-PTC (all P < .05). The results were significant in tumors ≥1.0 cm, whereas there were no significant differences in tumors <1 cm. As the number of malignant US features increased, multifocality, extrathyroidal extension, LN metastasis, and a higher stage were more likely. CONCLUSION PTCs that did not meet malignant US criteria had better prognostic indicators than PTCs that met US criteria. Therefore, US features at the time of diagnosis can serve as a useful tool for predicting biological behavior in PTC.

[1]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[2]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[3]  Evaluating the Degree of Conformity of Papillary Carcinoma and Follicular Carcinoma to the Reported Ultrasonographic Findings of Malignant Thyroid Tumor , 2007, Korean journal of radiology.

[4]  F. Rubino,et al.  Prognostic factors in differentiated thyroid carcinoma: A multivariate analysis of 234 consecutive patients , 1998, Journal of surgical oncology.

[5]  M. Castro,et al.  Approach to the patient with nontoxic multinodular goiter. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  P. Fu,et al.  Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. , 2010, Surgery.

[7]  Jeong Hyun Lee,et al.  Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. , 2008, Radiology.

[8]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[9]  A. Miyauchi,et al.  Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study. , 2012, Endocrine journal.

[10]  C. Hsueh,et al.  Papillary thyroid carcinoma with different histological patterns. , 2011, Chang Gung medical journal.

[11]  R. García-mayor,et al.  Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[12]  P. Neuhaus,et al.  Prognostic factors in patients with differentiated thyroid carcinoma. , 2000, The European journal of surgery = Acta chirurgica.

[13]  A. Miyauchi,et al.  Ultrasonographically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Relapse-free Survival in Patients with Papillary Thyroid Carcinoma , 2005, World Journal of Surgery.

[14]  Shuangge Ma,et al.  A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004. , 2009, Thyroid : official journal of the American Thyroid Association.

[15]  E. Ueno,et al.  Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. , 2005, Thyroid : official journal of the American Thyroid Association.

[16]  B. Caillou,et al.  Long‐term results and prognostic factors in patients with differentiated thyroid carcinoma , 1985, Cancer.

[17]  R. Owen,et al.  Aggressive variants of papillary thyroid carcinoma , 2011, Head & neck.

[18]  S. Suster,et al.  The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. , 1997, Human pathology.

[19]  Laurence Leenhardt,et al.  Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. , 2004, Thyroid : official journal of the American Thyroid Association.

[20]  S. Jhiang,et al.  Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.

[21]  M. Hirokawa,et al.  Excellent Prognosis of Patients with Nonhereditary Medullary Thyroid Carcinoma with Ultrasonographic Findings of Follicular Tumor or Benign Nodule , 2009, World Journal of Surgery.

[22]  Jin Young Kwak,et al.  Can vascularity at power Doppler US help predict thyroid malignancy? , 2010, Radiology.

[23]  B. Cha,et al.  Diagnostic value of ultrasonography to distinguish between benign and malignant lesions in the management of thyroid nodules. , 2007, Thyroid : official journal of the American Thyroid Association.

[24]  Anna Crescenzi,et al.  Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. , 2002, The Journal of clinical endocrinology and metabolism.

[25]  J. Cronan,et al.  Risk for Malignancy of Thyroid Nodules as Assessed by Sonographic Criteria , 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[26]  Matthew J Hayat,et al.  Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. , 2007, The oncologist.

[27]  J. Freeman,et al.  Management and outcome of recurrent well-differentiated thyroid carcinoma. , 2004, Archives of otolaryngology--head & neck surgery.

[28]  E. Kaplan,et al.  Natural history, treatment, and course of papillary thyroid carcinoma. , 1990, The Journal of clinical endocrinology and metabolism.

[29]  Dong Gyu Na,et al.  Ultrasonography and the Ultrasound-Based Management of Thyroid Nodules: Consensus Statement and Recommendations , 2011, Korean journal of radiology.

[30]  N. Wada,et al.  Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. , 2007, The Journal of clinical endocrinology and metabolism.

[31]  T. Carling,et al.  Special Variants of Differentiated Thyroid Cancer: Does It Alter the Extent of Surgery Versus Well-Differentiated Thyroid Cancer? , 2007, World Journal of Surgery.

[32]  A. Miyauchi,et al.  Long-term follow-up for patients with papillary thyroid carcinoma treated as benign nodules. , 2007, Anticancer research.

[33]  A. Miyauchi,et al.  Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid. , 2009, Endocrine journal.

[34]  Dong Ik Kim,et al.  New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. , 2002, AJR. American journal of roentgenology.